HOME Top Market Reports Biobanking Market by Product and Service(Equipment, Consumables, Services, Software), Sample Type (Blood Products, Human Tissues, Cell Lines, Nucleic Acids), Application( Regenerative Medicine, Life Science, Clinical Research) - Global Forecast to 2022

Biobanking Market by Product and Service(Equipment, Consumables, Services, Software), Sample Type (Blood Products, Human Tissues, Cell Lines, Nucleic Acids), Application( Regenerative Medicine, Life Science, Clinical Research) - Global Forecast to 2022

By: marketsandmarkets.com
Publishing Date: August 2017
Report Code: BT 1224

 

  Speak to Analyst Enquiry Before Buying Webinar
purchase report
download pdf  request for customisation


The biobanking market is expected to reach USD 2.69 Billion by 2022 from USD 1.72 Billion in 2016 at a CAGR of 7.8%. The base year for this study is 2016.

The objectives of this study are as follows:

  • To define, describe, and forecast the Global Biobanking market by product and service, sample type, storage type, application, and region
  • To provide detailed information regarding the major factors influencing growth of the Biobanking market (drivers, restraints, opportunities, and challenges)
  • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
  • To analyze the opportunities in the Biobanking market for stakeholders and provide details of a competitive landscape for market leaders
  • To forecast revenue of the market segments with respect to four main regional segments, namely, North America, Europe, Asia-Pacific, and the Rest of the World (RoW)
  • To profile key players and comprehensively analyze their market shares and core competencies in terms of market development and growth strategies
  • To track and analyze competitive developments such as agreements, collaborations, and partnerships; acquisitions; and product launches in the biobanking market

Research Methodology

Top-down and bottom-up approaches were used to estimate and validate the size of the Biobanking market and to estimate the size of various other dependent submarkets. The overall market size was used in the top-down approach to estimate the sizes of other individual submarkets (mentioned in the market segmentation by product and service, sample type, storage type, application, and region) through percentage splits from secondary and primary research. The bottom-up approach was also implemented (wherever applicable) for data extracted from secondary research to validate the market segment revenues obtained. Various secondary sources have been used to identify and collect information useful for this extensive commercial study of the biobanking market. Primary sources such as experts from related industries and suppliers have been interviewed to obtain and verify critical information as well as to assess prospects of the biobanking market. The breakdown of profiles of primaries is shown in the figure below:

Biobanking Market

To know about the assumptions considered for the study, download the pdf brochure

The key players in the biobanking market include Thermo Fisher Scientific Inc. (U.S.), Tecan Group Ltd. (Switzerland), Qiagen N.V. (Germany), Hamilton Company (U.S.), Brooks Automation (U.S.), TTP Labtech Ltd (U.K.), VWR Corporation (U.S.), Promega Corporation (U.S.), Worthington Industries [(Taylor Wharton, U.S.)],  Chart Industries (U.S.), Becton, Dickinson and Company (U.S.), Merck KGaA (Germany), Micronic (Netherlands), LVL Technologies GmbH & Co. KG (Germany), Panasonic Healthcare Holdings Co. Ltd (Japan), Greiner Bio One [Greiner Holding AG, Austria)], Biokryo GmbH (Germany), Biobank AS (Norway), Biorep Technologies Inc. (U.S.), Cell & Co Bioservices (France), RUCDR infinite biologics (U.S.), Modul-Bio (France), CSols Ltd (U.K.), Ziath (U.K.), and LabVantage Solutions Inc. (U.S.)

Target Audience for this Report:

  • Biobanking associations
  • Research & consulting firms
  • Distributors of biobanking research products
  • Contract manufacturers of biobanking equipment and consumables
  • Research institutes and clinical research organizations (CROs)
  • Venture capitalists
  • Government associations

Scope of the Report:

This report categorizes the biobanking market into the following segments:

  • By Product and Service
    • Equipment
    • Consumables
    • Services
    • Software
  • By Sample Type
    • Blood Products
    • Human Tissues
    • Nucleic Acids
    • Cell Lines
    • Biological Fluids
    • Human Waste Products
  • By Application
    • Regenerative Medicine
    • Life Science Research
    • Clinical Research
  • By Region
    • North America
      • U.S.
      • Canada
    • Europe
      • Germany
      • France
      • U.K.
      • Italy
      • Netherlands
      • Rest of Europe (RoE)
    • Asia-Pacific
      • Japan
      • India
      • China
      • Australia
      • Rest of Asia Pacific (RoAPAC)
    • Rest of the World (RoW)

Customization Options:

  • Company Information: Detailed company profiles of five or more market players
  • Opportunities Assessment: A detailed report underlining the various growth opportunities presented in the market

Table of Contents

1 Introduction (Page No. - 14)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
    1.4 Years Considered for the Study
    1.5 Currency
    1.6 Limitations
    1.7 Stakeholders

2 Research Methodology (Page No. - 17)
    2.1 Secondary Data
    2.2 Primary Data
    2.3 Market Size Estimation
           2.3.1 Bottom-Up Approach
           2.3.2 Top-Down Approach
    2.4 Market Breakdown & Data Triangulation
    2.5 Assumptions for the Study

3 Executive Summary (Page No. - 24)

4 Premium Insights (Page No. - 28)
    4.1 Biobanking: Market Overview
    4.2 Geographic Analysis: Biobanking Market, By Region & Sample Type (2017)
    4.3 Biobanking Market, By Product & Service, 2017–2022
    4.4 Geographical Snapshot of the Biobanking Market

5 Market Overview (Page No. - 31)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 Increasing Number of Genomics Research Activities for Studying Diseases
                    5.2.1.2 Advances in Biobanking and Growing Trend of Conserving Cord Blood Stem Cells of Newborns
                    5.2.1.3 Government & Private Funding to Support Regenerative Medicine Research
                    5.2.1.4 Growing Need for Cost-Effective Drug Discovery and Development
           5.2.2 Restraints
                    5.2.2.1 High Cost of Automation
                    5.2.2.2 Issues Related to Biospecimen Sample Procurement
           5.2.3 Opportunities
                    5.2.3.1 Emerging Countries
                    5.2.3.2 Growing Focus on the Research and Development of Cell Therapies
           5.2.4 Challenges
                    5.2.4.1 Long-Term Sustainability of Biobanks

6 Global Biobanking Market, By Product and Service (Page No. - 38)
    6.1 Introduction
    6.2 Equipment
           6.2.1 Storage Equipment
           6.2.2 Sample Analysis Equipment
           6.2.3 Sample Processing Equipment
           6.2.4 Sample Transport Equipment
    6.3 Consumables
           6.3.1 Storage Consumables
           6.3.2 Analysis Consumables
           6.3.3 Processing Consumables
           6.3.4 Collection Consumables
    6.4 Services
           6.4.1 Storage Services
           6.4.2 Processing Services
           6.4.3 Transport Services
           6.4.4 Supply Services
    6.5 Software

7 Global Biobanking Market, By Sample Type (Page No. - 52)
    7.1 Introduction
    7.2 Blood Products
    7.3 Human Tissues
    7.4 Cell Lines
    7.5 Nucleic Acids
    7.6 Biological Fluids
    7.7 Human Waste Products

8 Global Biobanking Market, By Storage Type (Page No. - 59)
    8.1 Introduction
    8.2 Manual Storage
    8.3 Automated Storage

9 Global Biobanking Market, By Application (Page No. - 63)
    9.1 Introduction
    9.2 Regenerative Medicine
    9.3 Life Science Research
    9.4 Clinical Research

10 Global Biobanking Market, By Region (Page No. - 68)
     10.1 Introduction
     10.2 North America
             10.2.1 U.S.
             10.2.2 Canada
     10.3 Europe
             10.3.1 Germany
             10.3.2 France
             10.3.3 U.K.
             10.3.4 Italy
             10.3.5 Netherlands
             10.3.6 Rest of Europe (RoE)
     10.4 Asia-Pacific
             10.4.1 China
             10.4.2 Japan
             10.4.3 India
             10.4.4 South Korea
             10.4.5 Australia
             10.4.6 Rest of Asia Pacific (RoAPAC)
     10.5 Rest of the World (RoW)

11 Competitive Landscape (Page No. - 124)
     11.1 Introduction
     11.2 Competitive Leadership Mapping
             11.2.1 Visionary Leaders
             11.2.2 Innovators
             11.2.3 Dynamic Differentiators
             11.2.4 Emerging Companies
     11.3 Competitive Benchmarking
             11.3.1 Strength of Product Portfolio
             11.3.2 Business Strategy Excellence
     11.4 Market Share Analysis

12 Company Profiles (Page No. - 129)
     12.1 Thermo Fisher Scientific Inc.
             12.1.1 Overview
             12.1.2 Strength of Product Portfolio
             12.1.3 Business Strategy Excellence
             12.1.4 Recent Developments
     12.2 Panasonic Healthcare Holdings Co., Ltd.
             12.2.1 Overview
             12.2.2 Strength of Product Portfolio
             12.2.3 Business Strategy Excellence
             12.2.4 Recent Developments
     12.3 Becton, Dickinson and Company
             12.3.1 Overview
             12.3.2 Strength of Product Portfolio
             12.3.3 Business Strategy Excellence
             12.3.4 Recent Developments
     12.4 Qiagen N.V.
             12.4.1 Overview
             12.4.2 Strength of Product Portfolio
             12.4.3 Business Strategy Excellence
             12.4.4 Recent Developments
     12.5 Merck KGaA
             12.5.1 Overview
             12.5.2 Strength of Product Portfolio
             12.5.3 Business Strategy Excellence
             12.5.4 Recent Developments
     12.6 VWR Corporation
             12.6.1 Overview
             12.6.2 Strength of Product Portfolio
             12.6.3 Business Strategy Excellence
             12.6.4 Recent Developments
     12.7 Tecan Trading AG
             12.7.1 Overview
             12.7.2 Strength of Product Portfolio
             12.7.3 Business Strategy Excellence
             12.7.4 Recent Developments
     12.8 Brooks Automation, Inc.
             12.8.1 Overview
             12.8.2 Strength of Product Portfolio
             12.8.3 Business Strategy Excellence
             12.8.4 Recent Developments
     12.9 Chart Industries, Inc.
             12.9.1 Overview
             12.9.2 Strength of Product Portfolio
             12.9.3 Business Strategy Excellence
             12.9.4 Recent Developments
     12.10 Hamilton Company
             12.10.1 Overview
             12.10.2 Strength of Product Portfolio
             12.10.3 Business Strategy Excellence
             12.10.4 Recent Developments
     12.11 Greiner Holding AG
             12.11.1 Overview
             12.11.2 Strength of Product Portfolio
             12.11.3 Business Strategy Excellence
             12.11.4 Recent Developments
     12.13 Promega Corporation
             12.13.1 Overview
             12.13.2 Strength of Product Portfolio
             12.13.3 Business Strategy Excellence
             12.13.4 Recent Developments

13 Appendix (Page No. - 162)
     13.1 Industry Insights
     13.2 Discussion Guide
     13.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
     13.4 Introducing RT: Real-Time Market Intelligence
     13.5 Available Customizations
     13.6 Related Reports
     13.7 Author Details


List of Tables (123 Tables)

Table 1 Biobanking: Market Snapshot
Table 2 Biobanking Market, By Product and Service, 2015–2022 (USD Million)
Table 3 Biobanking Equipment Market, By Region, 2015–2022 (USD Million)
Table 4 Biobanking Equipment Market, By Type, 2015–2022 (USD Million)
Table 5 Storage Equipment Market, By Region, 2015–2022 (USD Million)
Table 6 Sample Analysis Equipment Market, By Region, 2015–2022 (USD Million)
Table 7 Sample Processing Equipment Market, By Region, 2015–2022 (USD Million)
Table 8 Sample Transport Equipment Market, By Region, 2015–2022 (USD Million)
Table 9 Biobanking Consumables Market, By Region, 2015–2022 (USD Million)
Table 10 Biobanking Consumables Market, By Type, 2015–2022 (USD Million)
Table 11 Storage Consumables Market, By Region, 2015–2022 (USD Million)
Table 12 Analysis Consumables Market, By Region, 2015–2022 (USD Million)
Table 13 Processing Consumables Market, By Region, 2015–2022 (USD Million)
Table 14 Collection Consumables Market, By Region, 2015–2022 (USD Million)
Table 15 Biobanking Services Market, By Region, 2015–2022 (USD Million)
Table 16 Biobanking Services Market, By Type, 2015–2022 (USD Million)
Table 17 Storage Services Market, By Region, 2015–2022 (USD Million)
Table 18 Processing Services Market, By Region, 2015–2022 (USD Million)
Table 19 Transport Services Market, By Region, 2015–2022 (USD Million)
Table 20 Supply Services Market, By Region, 2015–2022 (USD Million)
Table 21 Biobanking Software Market, By Region, 2015–2022 (USD Million)
Table 22 Biobanking Market, By Sample Type, 2015–2022 (USD Million)
Table 23 Biobanking Market for Blood Products, By Region, 2015–2022 (USD Million)
Table 24 Biobanking Market for Human Tissues, By Region, 2015–2022 (USD Million)
Table 25 Biobanking Market for Cell Lines, By Region, 2015–2022 (USD Million)
Table 26 Biobanking Market for Nucleic Acids, By Region, 2015–2022 (USD Million)
Table 27 Biobanking Market for Biological Fluids, By Region, 2015–2022 (USD Million)
Table 28 Biobanking Market for Human Waste Products, By Region, 2015–2022 (USD Million)
Table 29 Biobanking Market, By Storage Type, 2015–2022 (USD Million)
Table 30 Biobanking Market for Manual Storage, By Region, 2015–2022 (USD Million)
Table 31 Biobanking Market for Automated Storage, By Region, 2015–2022 (USD Million)
Table 32 Biobanking Market, By Application, 2015–2022 (USD Million)
Table 33 Biobanking Market for Regenerative Medicine Applications, By Region, 2015–2022 (USD Million)
Table 34 Biobanking Market for Life Science Research Applications, By Region, 2015–2022 (USD Million)
Table 35 Biobanking Market for Clinical Research Applications, By Region, 2015–2022 (USD Million)
Table 36 Biobanking Market, By Region, 2015–2022 (USD Million)
Table 37 North America: Biobanking Market, By Country, 2015–2022 (USD Million)
Table 38 North America: Biobanking Market, By Product & Service, 2015–2022 (USD Million)
Table 39 North America: Biobanking Equipment Market, By Equipment Type, 2015–2022 (USD Million)
Table 40 North America: Biobanking Consumables Market, By Consumables Type, 2015–2022 (USD Million)
Table 41 North America: Biobanking Services Market, By Services Type, 2015–2022 (USD Million)
Table 42 North America: Biobanking Market, By Sample Type, 2015–2022 (USD Million)
Table 43 North America: Biobanking Market, By Storage Type, 2015–2022 (USD Million)
Table 44 North America: Biobanking Market, By Application, 2015–2022 (USD Million)
Table 45 U.S.: Biobanking Market, By Product & Service, 2015–2022 (USD Million)
Table 46 U.S.: Biobanking Market, By Sample Type, 2015–2022 (USD Million)
Table 47 U.S.: Biobanking Market, By Storage Type, 2015–2022 (USD Million)
Table 48 U.S.: Biobanking Market, By Application, 2015–2022 (USD Million)
Table 49 Canada: Biobanking Market, By Product & Service, 2015–2022 (USD Million)
Table 50 Canada: Biobanking Market, By Sample Type, 2015–2022 (USD Million)
Table 51 Canada: Biobanking Market, By Storage Type, 2015–2022 (USD Million)
Table 52 Canada: Biobanking Market, By Application, 2015–2022 (USD Million)
Table 53 Europe: Biobanking Market, By Country, 2015–2022 (USD Million)
Table 54 Europe: Biobanking Market, By Product & Service, 2015–2022 (USD Million)
Table 55 Europe: Biobanking Equipment Market, By Equipment Type, 2015–2022 (USD Million)
Table 56 Europe: Biobanking Consumables Market, By Consumables Type, 2015–2022 (USD Million)
Table 57 Europe: Biobanking Services Market, By Services Type, 2015–2022 (USD Million)
Table 58 Europe: Biobanking Market, By Sample Type 2015–2022 (USD Million)
Table 59 Europe: Biobanking Market, By Storage Type, 2015–2022 (USD Million)
Table 60 Europe: Biobanking Market, By Application, 2015–2022 (USD Million)
Table 61 Germany: Biobanking Market, By Product & Service, 2015–2022 (USD Million)
Table 62 Germany: Biobanking Market, By Sample Type, 2015–2022 (USD Million)
Table 63 Germany: Biobanking Market, By Storage Type, 2015–2022 (USD Million)
Table 64 Germany: Biobanking Market, By Application, 2015–2022 (USD Million)
Table 65 France: Biobanking Market, By Product & Service, 2015–2022 (USD Million)
Table 66 France: Biobanking Market, By Sample Type, 2015–2022 (USD Million)
Table 67 France: Biobanking Market, By Storage Type, 2015–2022 (USD Million)
Table 68 France: Biobanking Market, By Application, 2015–2022 (USD Million)
Table 69 U.K.: Biobanking Market, By Product & Service, 2015–2022 (USD Million)
Table 70 U.K.: Biobanking Market, By Sample Type, 2015–2022 (USD Million)
Table 71 U.K.: Biobanking Market, By Storage Type, 2015–2022 (USD Million)
Table 72 U.K.: Biobanking Market, By Application, 2015–2022 (USD Million)
Table 73 Italy: Biobanking Market, By Product & Service, 2015–2022 (USD Million)
Table 74 Italy: Biobanking Market, By Sample Type, 2015–2022 (USD Million)
Table 75 Italy: Biobanking Market, By Storage Type, 2015–2022 (USD Million)
Table 76 Italy: Biobanking Market, By Application, 2015–2022 (USD Million)
Table 77 Netherlands: Biobanking Market, By Product & Service, 2015–2022 (USD Million)
Table 78 Netherlands: Biobanking Market, By Sample Type, 2015–2022 (USD Million)
Table 79 Netherlands: Biobanking Market, By Storage Type, 2015–2022 (USD Million)
Table 80 Netherlands: Biobanking Market, By Application, 2015–2022 (USD Million)
Table 81 RoE: Biobanking Market, By Product & Service, 2015–2022 (USD Million)
Table 82 RoE: Biobanking Market, By Sample Type, 2015–2022 (USD Million)
Table 83 RoE: Biobanking Market, By Storage Type, 2015–2022 (USD Million)
Table 84 RoE: Biobanking Market, By Application, 2015–2022 (USD Million)
Table 85 Asia-Pacific: Biobanking Market, By Country, 2015–2022 (USD Million)
Table 86 Asia-Pacific: Biobanking Market, By Product & Service, 2015–2022 (USD Million)
Table 87 Asia-Pacific: Biobanking Equipment Market, By Equipment Type, 2015–2022 (USD Million)
Table 88 Asia-Pacific: Biobanking Consumables Market, By Consumables Type, 2015–2022 (USD Million)
Table 89 Asia-Pacific: Biobanking Services Market, By Services Type, 2015–2022 (USD Million)
Table 90 Asia-Pacific: Biobanking Market, By Sample Type, 2015–2022 (USD Million)
Table 91 Asia-Pacific: Biobanking Market, By Storage Type, 2015–2022 (USD Million)
Table 92 Asia-Pacific: Biobanking Market, By Application, 2015–2022 (USD Million)
Table 93 China: Biobanking Market, By Product & Service, 2015–2022 (USD Million)
Table 94 China: Biobanking Market, By Sample Type, 2015–2022 (USD Million)
Table 95 China: Biobanking Market, By Storage Type, 2015–2022 (USD Million)
Table 96 China: Biobanking Market, By Application, 2015–2022 (USD Million)
Table 97 Japan: Biobanking Market, By Product & Service, 2015–2022 (USD Million)
Table 98 Japan: Biobanking Market, By Sample Type, 2015–2022 (USD Million)
Table 99 Japan: Biobanking Market, By Storage Type, 2015–2022 (USD Million)
Table 100 Japan: Biobanking Market, By Application, 2015–2022 (USD Million)
Table 101 India: Biobanking Market, By Product, 2015–2022 (USD Million)
Table 102 India: Biobanking Market, By Sample Type, 2015–2022 (USD Million)
Table 103 India: Biobanking Market, By Storage Type, 2015–2022 (USD Million)
Table 104 India: Biobanking Market, By Application, 2015–2022 (USD Million)
Table 105 South Korea: Biobanking Market, By Product & Service, 2015–2022 (USD Million)
Table 106 South Korea: Biobanking Market, By Sample Type, 2015–2022 (USD Million)
Table 107 South Korea: Biobanking Market, By Storage Type, 2015–2022 (USD Million)
Table 108 South Korea: Biobanking Market, By Application, 2015–2022 (USD Million)
Table 109 Australia: Biobanking Market, By Product & Service, 2015–2022 (USD Million)
Table 110 Australia: Biobanking Market, By Sample Type, 2015–2022 (USD Million)
Table 111 Australia: Biobanking Market, By Storage Type, 2015–2022 (USD Million)
Table 112 Australia: Biobanking Market, By Application, 2015–2022 (USD Million)
Table 113 RoAPAC: Biobanking Market, By Product & Service, 2015–2022 (USD Million)
Table 114 RoAPAC: Biobanking Market, By Sample Type, 2015–2022 (USD Million)
Table 115 RoAPAC: Biobanking Market, By Storage Type, 2015–2022 (USD Million)
Table 116 RoA: Biobanking Market, By Application, 2015–2022 (USD Million)
Table 117 RoW: Biobanking Market, By Product & Service, 2015–2022 (USD Million)
Table 118 RoW: Biobanking Equipment Market, By Equipment Type, 2015–2022 (USD Million)
Table 119 RoW: Biobanking Consumables Market, By Consumables Type, 2015–2022 (USD Million)
Table 120 RoW: Biobanking Services Market, By Services Type, 2015–2022 (USD Million)
Table 121 RoW: Biobanking Market, By Sample Type, 2015–2022 (USD Million)
Table 122 RoW: Biobanking Market, By Storage Type, 2015–2022 (USD Million)
Table 123 RoW: Biobanking Market, By Application, 2015–2022 (USD Million)


List of Figures (38 Figures)

Figure 1 Research Design
Figure 2 Key Data From Secondary Sources
Figure 3 Key Data From Primary Sources
Figure 4 Biobanking Market: Bottom-Up Approach
Figure 5 Top-Down Approach
Figure 6 Data Triangulation Methodology
Figure 7 Biobanking Market, By Product & Service, 2017 vs 2022 (USD Billion)
Figure 8 Biobanking Market, By Sample Type, 2017 vs 2022 (USD Billion)
Figure 9 Biobanking Market, By Storage Type, 2017 vs 2022 (USD Billion)
Figure 10 Biobanking Market, By Application, 2017 vs 2022 (USD Billion)
Figure 11 Biobanking Market, By Region, 2017 vs 2022 (USD Billion)
Figure 12 Increasing Number of Genomics Research Activities and the Need for Cost-Efficient Drug Discovery are Driving the Growth of the Biobanking Market
Figure 13 North America is Estimated to Command the Largest Market Share in 2017
Figure 14 Equipment Segment to Register the Highest CAGR During the Forecast Period
Figure 15 APAC to Register the Highest CAGR Between 2017 & 2022
Figure 16 Biobanking Market: Drivers, Restraints, Opportunities, and Challenges
Figure 17 Equipment Segment to Dominate the Biobanking Market During the Forecast Period
Figure 18 Storage Equipment Segment to Dominate the Biobanking Equipment Market in 2017–2022
Figure 19 Blood Products Segment to Dominate the Biobanking Market During the Forecast Period
Figure 20 Manual Storage Segment Will Continue to Dominate the Biobanking Market in 2022
Figure 21 Regenerative Medicine to Dominate the Biobanking Applications Market During the Forecast Period
Figure 22 Asia-Pacific to Register the Highest Growth Rate in the Biobanking Market During the Forecast Period
Figure 23 North America: Biobanking Market Snapshot
Figure 24 Biobanking Equipment to Account for the Largest Share of the U.S. Market in 2017
Figure 25 Europe: Market Snapshot
Figure 26 Blood Products Segment to Register the Highest CAGR in the German Biobanking Sample Type Market During the Forecast Period
Figure 27 Asia-Pacific: Biobanking Market Snapshot
Figure 28 RoW: Biobanking Market Snapshot
Figure 29 Biobanking Market (Global) Competitive Leadership Mapping, 2017
Figure 30 Biobanking Market: Market Share (2016)
Figure 31 Thermo Fisher Scientific Inc.: Company Snapshot (2016)
Figure 32 Becton, Dickinson and Company: Company Snapshot (2016)
Figure 33 Qiagen N.V.: Company Snapshot (2016)
Figure 34 Merck KGaA: Company Snapshot (2016)
Figure 35 VWR Corporation: Company Snapshot (2016)
Figure 36 Tecan Trading AG.: Company Snapshot (2016)
Figure 37 Brooks Automation, Inc.: Company Snapshot (2016)
Figure 38 Chart Industries, Inc.: Company Snapshot (2016)

The global Biobanking market is expected to reach USD 2.69 Billion by 2022 from USD 1.85 Billion in 2017, at a CAGR of 7.8%. A number of factors such as increasing number of genomics research activities for studying diseases, advances in biobanking and growing trend of conserving cord blood stem cells of newborns and government & private funding to support regenerative medicine research in biobanking are expected to drive the growth of Biobanking market.

The global Biobanking market is segmented by product and service, sample type, storage type, application and regions. By product and service, the biobanking market is segmented into equipment, consumables, services and software. The equipment segment is expected to lead the global biobanking market in 2017. Factors such as the growth in the number of biobanks and number of biosamples to be stored are increasing the demand for biobanking equipment.

By sample type, the Biobanking market is classified into blood products, human tissues, cell lines, nucleic acids, human waste products, and biological fluids. Since blood and blood products are the most collected specimens and are used as a source of DNA and RNA, this segment type holds the largest share of the market.

On the basis of applications, the Biobanking market is segmented into regenerative medicine, life science research, and clinical research. Regenerative Medicine is expected to account for the largest share of the market in 2017 on the basis of applications. Growing research in regenerative medicine and the increasing demand for well characterized and quality biosamples for research are prime reasons for the growth of this market segment.

By storage type, the Biobanking market is segmented into manual storage and automated storage. In 2017, the manual storage segment is estimated to account for the largest share and the automated storage segment is projected to grow at the highest CAGR during the forecast period.

Biobanking Market

The global Biobanking market is dominated by North America, followed by Europe. North America will continue to dominate the global biobanking market in the forecast period. However, Asia-Pacific is expected to witness the highest CAGR, with the growth in this market centered at Japan, China, and India. Improving life sciences research infrastructure in emerging economies and growing government investment in biomedical, pharmaceutical, and biotechnology industries are some of the factors propelling market growth in the Asia-Pacific region.

The high cost of automation and issues related to biospecimen sample procurement are expected to restrain the market growth to a certain extent.

Major industry players launched innovative products to maintain and improve their position in the global Biobanking market. Hamilton Company (U.S.), Thermo Fisher Scientific Inc. (U.S.), Brooks Automation (U.S.), and Panasonic Healthcare Holdings Co. Ltd (Japan) have been identified as the top players in this market. These companies have a broad product portfolio with comprehensive features and have also launched innovative products. These leaders also have products for all end users in this market, a strong geographical presence, and they focus on continuous product innovations.

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports



Access reports on all high
growth Biomarkers Markets on KnowledgeStore
Request Demo